ArticleCurrent medical imaging2025
Automated Brain Tumor segmentation using hybrid YOLO and SAM.
Article in Current medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEarly-stage Brain tumor detection is critical for timely diagnosis and effective treatment. We propose a hybrid deep learning method, Convolutional Neural Network (CNN) integrated with YOLO (You Only Look once) and SAM (Segment Anything Model) for diagnosing tumors.
methodsA novel hybrid deep learning framework combining a CNN with YOLOv11 for real-time object detection and the SAM for precise segmentation. Enhancing the CNN backbone with deeper convolutional layers to enable robust feature extraction, while YOLOv11 localizes tumor regions, SAM is used to refine the tumor boundaries through detailed mask generation.
resultsA dataset of 896 MRI brain images is used for training, testing, and validating the model, including images of both tumors and healthy brains. Additionally, CNN-based YOLO+SAM methods were utilized successfully to segment and diagnose brain tumors. DISCUSSION: Our suggested model achieves good performance of Precision as 94.2%, Recall as 95.6% and mAP50(B) score as 96.5% demonstrating and highlighting the effectiveness of the proposed approach for early-stage brain tumor diagnosis Conclusion: The validation is demonstrated through a comprehensive ablation study. The robustness of the system makes it more suitable for clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.